- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Hypercalcemia of Malignancy in Japan
Total 380 results
-
AstraZenecaRecruitingHyperkalaemiaChina, Germany, United States, Ukraine, Spain, Japan, United Kingdom, Canada, Poland, Romania, Russian Federation, Brazil
-
Zeria PharmaceuticalCompleted
-
Zeria PharmaceuticalCompleted
-
Shoichi Fujii, MD, PhDUnknownMalignant Neoplasm of Transverse Colon | Malignant Neoplasm of Descending ColonJapan
-
AstraZenecaCompletedAdvanced Solid Tumor | Advanced Solid MalignancyJapan
-
SanofiCompleted
-
Kyowa Kirin Co., Ltd.CompletedPrimary Hyperparathyroidism | Parathyroid CarcinomaJapan
-
Kyowa Kirin Co., Ltd.CompletedPrimary Hyperparathyroidism | Parathyroid Carcinoma | HypercalcemiaJapan
-
GenmabBioNTech SERecruitingMalignant Solid TumorJapan
-
Eli Lilly and CompanyCompletedMetastasis | MalignancyJapan
-
Daiichi Sankyo Co., Ltd.Completed
-
Daiichi Sankyo Co., Ltd.Terminated
-
Kochi UniversityAvailableBoth Benign and Malignant Liver MassJapan
-
Daiichi Sankyo Co., Ltd.AstraZenecaCompletedMalignant Neoplasm of BreastJapan
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdCompletedMalignant TumorsJapan
-
PfizerCompletedNeoplasm, MalignantJapan
-
Puma Biotechnology, Inc.CompletedAdvanced Malignant Solid TumorsJapan
-
Puma Biotechnology, Inc.Completed
-
Puma Biotechnology, Inc.CompletedAdvanced Malignant Solid TumorsJapan
-
Ono Pharmaceutical Co. LtdCompletedMalignant Solid TumorJapan
-
Astellas Pharma IncCompletedHealthy | Pharmacokinetics of ASP1941 | Pharmacokinetics of MitiglinideJapan
-
Osaka Metropolitan UniversityMayo Clinic; Istituto Ortopedico Rizzoli; Hospital for Special Surgery, New YorkActive, not recruiting
-
SanofiCompletedNeoplasm MalignantJapan
-
Daiichi Sankyo Co., Ltd.CompletedAdvanced Solid Malignant TumorsJapan
-
SanofiCompletedNeoplasm MalignantJapan
-
SanofiCompleted
-
Taisho Pharmaceutical Co., Ltd.Completed
-
Bristol-Myers SquibbOno Pharma USA IncCompletedCancer of Head and Neck | Cancer of the Head | Cancer of the NeckJapan
-
AstraZenecaCompletedHyperkalemiaKorea, Republic of, Taiwan, Russian Federation, Japan
-
Astellas Pharma IncCompletedHealthy | Pharmacokinetics of ASP7991Japan
-
Astellas Pharma IncCompletedHealthy | Pharmacokinetics of ASP0456Japan
-
Astellas Pharma IncCompletedHealthy | Pharmacokinetics of ASP0456Japan
-
Astellas Pharma IncCompletedHealthy | Pharmacokinetics of YM150Japan
-
Astellas Pharma IncCompletedHealthy | Pharmacokinetics of QuetiapineJapan
-
Astellas Pharma IncCompletedA Study to Investigate the Effect of Food on the Absorption, Distribution and Elimination of ASP1941Healthy | Pharmacokinetics of ASP1941Japan
-
Astellas Pharma IncCompletedHealthy | Pharmacokinetics of AtorvastatinJapan
-
Astellas Pharma IncCompletedHealthy | Pharmacokinetics of EnalaprilJapan
-
Kurume UniversityUnknownTo Evaluate the Effect of Pioglitazone on Glucose Metabolism of Fat Tissue by Using FDG-PET/CT ImagingJapan
-
Astellas Pharma IncCompletedA Study to Evaluate the Safety of ASP2408 After Subcutaneous Administration to Healthy Male SubjectsHealthy | Pharmacokinetics of ASP2408Japan
-
Astellas Pharma IncCompletedHealthy | Pharmacokinetics of ASP7991Japan
-
Astellas Pharma IncCompletedHealthy | Pharmacokinetics of ValsartanJapan
-
Astellas Pharma IncCompletedHealthy | Plasma Concentration of YM060Japan
-
Astellas Pharma IncCompletedHealthy | Plasma Concentration of ASP1941Japan
-
Astellas Pharma IncCompletedHealthy | Plasma Concentration of YM060Japan
-
Astellas Pharma IncCompletedHealthy Volunteer | Pharmacokinetics of YM150Japan
-
AstraZenecaCompleted
-
Astellas Pharma IncCompletedHealthy | Plasma Concentration Change of QuetiapineJapan
-
Astellas Pharma IncCompletedHealthy Subjects | Plasma Concentration of MirabegronJapan
-
Astellas Pharma IncCompletedHealthy Volunteer | Pharmacokinetics of ASP015KJapan